Stock Screener App

무료 -

7.93

5.40% 0.43

리커젼 파마 (RXRX)

개요 뉴스 가격 이력 옵션 체인 Financials RXRX 왜 하락? 토론 예측

Recursion Pharmaceuticals Inc 주식(RXRX)의 최신 뉴스

Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening? - MSN

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Tina Marriott Sells 6000 Shares of Stock - Defense World

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling - Defense World

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Sells 6,000 Shares of Stock - MarketBeat

Recursion Pharmaceuticals COO sells shares worth over $43,000 By Investing.com - Investing.com

Recursion Pharmaceuticals COO sells shares worth over $43,000 By Investing.com - Investing.com

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Recursion Pharmaceuticals COO sells shares worth over $43,000 By Investing.com - Investing.com UK

Investing.com UK

KORE Group announces reverse stock split effective July 1 By Investing.com - Investing.com Canada

Investing.com Canada

Recursion (RXRX) Up on $50M NVDA Investment for AI Drug Discovery - Yahoo Canada Shine On

Yahoo Canada Shine On

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 3.7% Following Insider Selling - MarketBeat

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX) - Yahoo Finance

Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX) By GuruFocus - Investing.com Canada

Investing.com Canada

Recursion Pharmaceuticals stock soars following $50 million investment from AI chipmaker Nvidia - MSN

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn't Discovered Yet - InvestorPlace

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells 11,447 Shares of Stock - MarketBeat

Recursion Pharmaceuticals director sells shares worth over $108k By Investing.com - Investing.com Australia

Investing.com Australia

Mario Gabelli's GAMCO investors buys $19940 of Atlanta Braves holdings stock By Investing.com - Investing.com

Recursion Pharmaceuticals director sells shares worth over $108k By Investing.com - Investing.com

Recursion Pharmaceuticals director sells shares worth over $108k By Investing.com - Investing.com UK

Investing.com UK

Atlassian co-CEO Cannon-Brookes sells over $1.35 million in company stock By Investing.com - Investing.com

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $8.76 - MarketBeat

Recursion Pharmaceuticals Shares Drop 19% After Public Offering Prices - MarketWatch

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

Why Recursion Pharmaceuticals Stock Is Tumbling Thursday - Recursion Pharmaceuticals (NASDAQ:RXRX) - Benzinga

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

What's Going On With Recursion Pharmaceuticals Stock Monday? - Quantisnow

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On? - MSN

Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock - StockTitan

Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock

GlobeNewswire Inc.

Recursion Pharmaceuticals plans $200 million stock offering By Investing.com - Investing.com Australia

Investing.com Australia

3 AI Stocks on the Edge of a Massive Surge - InvestorPlace

Recursion Pharmaceuticals plans $200 million stock offering By Investing.com - Investing.com South Africa

Investing.com South Africa

Recursion Pharmaceuticals plans $200 million stock offering By Investing.com - Investing.com

Vascular Malformations Market to Grow Substantially by 2034, Assesses DelveInsight | Key Companies – ARTham ... - The Malaysian Reserve

The Malaysian Reserve

Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 4.4% - MarketBeat

Recursion Pharmaceuticals Down 7.9% on Planned Secondary Offering - MarketWatch

Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On? - Recursion Pharmaceuticals (NASDAQ ... - Benzinga

$83.42

1.34%

$25.09

0.04%

$147.26

3.54%

$80.44

0.01%

$434.05

0.83%

$245.11

0.76%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | Open in MarketWatch | Open in EDGAR | Open in Reuters